Archive - April 2018
Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for Azedra (iobenguane I 131)
Antares Pharma Provides Xyosted (testosterone enanthate subcutaneous injection) Regulatory Update
CPhI South East Asia to Open Thailand Edition in 2019
NHS England backs new innovations for NHS use
NICE u-turn sees Roche’s Tecentriq backed for lung cancer
New US approval for Clovis’ Rubraca
Incyte/MSD’s immunotherapy combo fails in Phase III
Novartis buys gene therapy co. for $8.7B